Riccardo Di Santo

Riccardo Di Santo

Auto-generated profile, based on publicly available information

Riccardo Di Santo

Dipartimento di Neuroscienze, Sezione di Fisica, Università Cattolica del Sacro Cuore, 00168, Rome, Italy; Department of Life Science, Health, and Health Professions, Link Campus University, Rome, 00165, Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2022 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
MNMatteo Nardini
Matteo Nardini
GCGabriele Ciasca
Gabriele Ciasca
ALAlessandra Lauria
Alessandra Lauria
CRCristina Rossi
Cristina Rossi
FGFlavio Di Giacinto
Flavio Di Giacinto
Marco De SpiritoMarco De Spirito
Marco De Spirito
Red blood cells (RBCs) are characterized by a remarkable elasticity, which allows them to undergo very large deformation when passing through small vessels and capillaries. This extreme deformability is altered in various clinical conditions, suggesting that the analysis of red blood cell (RBC) mechanics has potential applications in the search for non-invasive and cost-effective blood biomarkers. Here, we provide a comparative study of the mechanical response of RBCs in patients with Alzheimer’s disease (AD) and healthy subjects. For this purpose, RBC viscoelastic response was investigated using atomic force microscopy (AFM) in the force spectroscopy mode. Two types of analyses were performed: (i) a conventional analysis of AFM force–distance (FD) curves, which allowed us to retrieve the apparent Young’s modulus, E; and (ii) a more in-depth analysis of time-dependent relaxation curves in the framework of the standard linear solid (SLS) model, which allowed us to estimate cell viscosity and elasticity, independently. Our data demonstrate that, while conventional analysis of AFM FD curves fails in distinguishing the two groups, the mechanical parameters obtained with the SLS model show a very good classification ability. The diagnostic performance of mechanical parameters was assessed using receiving operator characteristic (ROC) curves, showing very large areas under the curves (AUC) for selected biomarkers (AUC > 0.9). Taken all together, the data presented here demonstrate that RBC mechanics are significantly altered in AD, also highlighting the key role played by viscous forces. These RBC abnormalities in AD, which include both a modified elasticity and viscosity, could be considered a potential source of plasmatic biomarkers in the field of liquid biopsy to be used in combination with more established indicators of the pathology.

9 July 2024 in Analytica Chimica Acta
Verified
Journal Article
Open access
RSR. Di Santo
R. Di Santo
FVF. Verdelli
F. Verdelli
BNB. Niccolini
B. Niccolini
SVS. Varca
S. Varca
AGA. del Gaudio
A. del Gaudio
GCGabriele Ciasca
Gabriele Ciasca
Hepatocellular carcinoma (HCC) is the most common form of liver cancer, with cirrhosis being a major risk factor. Traditional blood markers like alpha-fetoprotein (AFP) demonstrate limited efficacy in distinguishing between HCC and cirrhosis, underscoring the need for more effective diagnostic methodologies. In this context, extracellular vesicles (EVs) have emerged as promising candidates; however, their practical diagnostic application is restricted by the current lack of label-free methods to accurately profile their molecular content. To address this gap, our study explores the potential of mid-infrared (mid-IR) spectroscopy, both alone and in combination with plasmonic nanostructures, to detect and characterize circulating EVs. EVs were extracted from HCC and cirrhotic patients. Mid-IR spectroscopy in the Attenuated Total Reflection (ATR) mode was utilized to identify potential signatures for patient classification, highlighting significant changes in the Amide I-II region (1475-1700 cm-1). This signature demonstrated diagnostic performance comparable to AFP and surpassed it when the two markers were combined. Further investigations utilized a plasmonic metasurface suitable for ultrasensitive spectroscopy within this spectral range. This device consists of two sets of parallel rod-shaped gold nanoantennas (NAs); the longer NAs produced an intense near-field amplification in the Amide I-II bands, while the shorter NAs were utilized to provide a sharp reflectivity edge at 1800-2200 cm-1 for EV mass-sensing. A clinically relevant subpopulation of EVs was targeted by conjugating NAs with an antibody specific to Epithelial Cell Adhesion Molecule (EpCAM). This methodology enabled the detection of variations in the quantity of EpCAM-presenting EVs and revealed changes in the Amide I-II lineshape. The presented results can positively impact the development of novel laboratory methods for the label-free characterization of EVs, based on the combination between mid-IR spectroscopy and plasmonics. Additionally, data obtained by using HCC and cirrhotic subjects as a model system, suggest that this approach could be adapted for monitoring these conditions.

15 December 2025 in Analytica Chimica Acta
Verified
Journal Article
Closed access
BNBenedetta Niccolini
Benedetta Niccolini
RSRiccardo Di Santo
Riccardo Di Santo
FGFlavio Di Giacinto
Flavio Di Giacinto
LTLinda Tartaglione
Linda Tartaglione
ARAlessandro Rizzi
Alessandro Rizzi
GCGabriele Ciasca
Gabriele Ciasca

1 October 2020 in Journal of the American College of Surgeons
Verified
Journal Article
Open access
PDF file
Damiano CaputoDamiano Caputo
Damiano Caputo
CCChiara Cascone
Chiara Cascone
RSRiccardo Di Santo
Riccardo Di Santo
LDLuca Digiacomo
Luca Digiacomo
EQErica Quagliarini
Erica Quagliarini
Giulio CaraccioloGiulio Caracciolo
Giulio Caracciolo
Nanomaterials exposed to human plasma (HP) are immediately covered by a protein corona (PC) whose composition is personalized, ie it depends on interindividual changes of the human proteome as those induced by several human diseases. Latest studies have shown that characterization of the personalized “disease-specific” PC can be successfully exploited for early detection of cancer.